Meitheal Pharmaceuticals said it has acquired the North American rights to a novel antibiotic for treating complicated urinary tract infections. The company said yesterday it's buying Contepo ...
“The escalating public health issue of antimicrobial resistance and emergence of highly resistant organisms demands immediate attention and innovative therapeutic solutions. The approval of CONTEPO is ...
CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...
Meitheal, a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic injectables, fertility, biologic and branded products, today ...
Fosfomycin has a novel mechanism of action and is the only IV-administered epoxide antibacterial antibiotic approved in the US Approval marks the second branded product in Meitheal’s portfolio and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results